APAC Atherectomy Devices Market

APAC Atherectomy Devices Market Size (2023 to 2028)

The atherectomy devices market size in the Asia Pacific is estimated to grow from USD 88.32 million in 2023 to USD 124.4 million by 2028, growing at a CAGR of 7.1% from 2023 to 2028.

Growing demand for minimally invasive surgical procedures and increasing research and development activities in this region are primarily accelerating market growth. The rising amount spent on healthcare and the standard increase of peripheral artery diseases (PAD) is likely to fuel the Asia Pacific atherectomy devices market during the analysis period. Additionally, rising knowledge levels among patients regarding the diagnosis of peripheral coronary diseases and growing medical reimbursement policies for the vascular treatment processes are expected to lavish the growth rate of the market. Also, the clinical advantages provided and the continuous technological advancements in atherectomy devices are further estimated to support the market growth in this region.

Notably, lack of awareness regarding the associated with among people and high costs associated with the treatment options using atherectomy devices are majorly impeding the market growth. Strict regulatory frameworks for the approval of the atherectomy devices and alternative therapies available in the market are expected to restrict the market growth in the Asia Pacific to some extent.

This research report on the Asia-Pacific Atherectomy Devices Market has been segmented and sub-segmented into the following categories:

By Type: 

• Directional
• Rotational
• Orbital
• Lateral

By Application: 

• Peripheral
• Cardiovascular
• Neurovascular

By End User: 

• Hospitals
• Surgical Centers
• Research Laboratories
• Academic Institutes

By Country: 

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Regionally, the Asia Pacific Atherectomy Devices Market will exhibit the highest growth rate in the forecast period because of the developing economy and increased healthcare costs.

The Chinese Atherectomy Devices Market dominates the APAC region and is expected to continue its dominance in the forthcoming years. The market size value of China is expected to be worth USD 54.3 Million by 2024 with a CAGR of 5.9% from 2020 to 2025 owing to the developing economy and growing healthcare expenditure in this region.

The Indian Atherectomy Devices Market is estimated to have a bright future during the forecast period and is predicted to showcase a CAGR value of 7.1% over the forecast period. Factors such as socioeconomic changes like smoking, unhealthy diet and consumption of liquor, and the aging population increase aimed diseases, which will demand market growth.

The Japanese Atherectomy Devices Market size value is expected to have a CAGR value of 6.8% during the forecast period.

Key market participants dominating the APAC Atherectomy Devices Market profiled in the report are Bayer HealthCare, C. R. Bard, Inc., Cardinal Health (Cordis), Avinger, Inc., Boston Scientific Corporation, Straub Medical AG, St. Jude Medical, Cardiovascular Systems, Inc., and Spectranetics.